aminocaproic acid has been researched along with Bone Fractures in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, L | 1 |
| Xu, Y | 1 |
| Wang, Y | 1 |
| Liu, Y | 1 |
| Huang, Q | 1 |
1 trial available for aminocaproic acid and Bone Fractures
| Article | Year |
|---|---|
Local administration of epsilon-aminocaproic acid reduces post-operative blood loss from surgery for closed, Sanders III-IV calcaneal fractures.
Topics: Aminocaproic Acid; Blood Loss, Surgical; Calcaneus; Fracture Fixation, Internal; Fractures, Bone; Hu | 2022 |